The FY26 Breast Cancer Research Program Clinical Research Extension Award funds projects that extend data collection, follow-up, and analysis in breast cancer clinical studies. It aims to increase clinical impact by addressing issues like early trial termination and limited patient follow-up. Teams must include breast cancer consumer advocates and may have one or two principal investigators, with specific application requirements for partnering PIs.
Open to any type of entity, with possible clarifications in additional eligibility information. Requires research teams to include two or more breast cancer consumer advocates.
